Mutation screening for thrombophilia: Two cases with factor V cambridge without activated protein C resistance

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 919-920

  Ten Cate, A J ^a   Van De Hoek, Y T ^a   Reitsma, P H ^a   Ten Cate, H ^a   Smits, P ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AMINO ACID; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTERY THROMBOSIS; ASSAY; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0036257346     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613108     Document Type: Letter

References (6)

1. Automated, simultaneous detection of the factor V Leiden and prothrombin (G20210A) variants using multiplex PCR and a line probe assay
2. Genetic principles underlying disorders of procoagulant and anticoagulant proteins
3. Factor V Cambridge: A new mutation (Arg 306-thr) associated with resistance to activated protein C
4. The prevalence of factor V Arg 306-Thr (factor V Cambridge) and factor V Arg 306-Gly mutations in different human populations
5. Mutations in coagulation factors in women with unexplained late fetal loss
6. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease